Navigation Links
Mayo Clinic: Proton therapy has advantages over IMRT for advanced head and neck cancers
Date:7/1/2014

Rochester, Minn. -- A new study by radiation oncologists at Mayo Clinic comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free survival and tumor control when compared to IMRT. The results appear in the journal Lancet Oncology.

"We undertook a systematic review and meta-analysis to compare the clinical outcomes of patients treated with proton therapy with patients receiving photon IMRT," says senior author Robert Foote, M.D., a radiation oncologist at Mayo Clinic. "Our findings suggest that the theoretical advantages of proton beam therapy may in fact be real."

Researchers reviewed studies of nasal cavity and paranasal sinus tumors through extensive database searches. They included studies of patients who had no previous treatment neither primary radiation therapy nor adjuvant radiation therapy -- and patients who had recurrent disease. Researchers collected data on overall survival, disease-free survival, and tumor control, at five years and at the patient's longest follow-up. They used random-effect models to pool outcomes across studies and compared event rates of combined outcomes for proton therapy and IMRT using an interaction test.

Researchers found disease free survival to be significantly higher at five years for patients receiving proton therapy than for patients receiving IMRT (72% versus 50%). Tumor control did not differ between treatment groups at five years however tumor control was higher for patients receiving proton therapy than for IMRT at the longest follow-up (81% versus 64%).


'/>"/>

Contact: Joe Dangor
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1

Related medicine news :

1. Mayo Clinic: Ovarian cancer subtypes may predict response to bevacizumab
2. Mayo Clinic: Drug induces morphologic, molecular and clinical remissions in myelofibrosis
3. Mayo Clinic: Add bone deterioration to diabetes complications
4. Mayo Clinic: Researchers to study bodys defense system to find new treatments for Alzheimers
5. Mayo Clinic: Less-invasive option as effective as esophagus removal in early esophageal cancer
6. Mayo Clinic: Enhanced recovery pathway for gynecologic surgery gets patients back to health faster
7. Mayo Clinic: Preclinical tests may lead to new approach to treat CNS lymphoma
8. Mayo Clinic: Rotavirus vaccine given to newborns in Africa is effective
9. Mayo Clinic: How gold nanoparticles can help fight ovarian cancer
10. Mayo Clinic: Inflammatory bowel disease raises risk of melanoma
11. Mayo Clinic: Scheduled imaging studies provide little help detecting relapse of aggressive lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... After months of negotiations, FaceCradle USA is ... Network on Wednesday, June 21. , “Introducing our product on QVC is something we ... to promote our travel pillow to more than 90 million homes in the United States,” ...
(Date:6/20/2017)... ... June 20, 2017 , ... EdChoice and the ... school choice can promote economic development in economically distressed urban areas. The first ... the report, contributed to the economic development of the city of Santa Ana, ...
(Date:6/20/2017)... Cincinnati, Ohio (PRWEB) , ... June 20, 2017 ... ... with gum disease in Cincinnati, OH for leading-edge care, whether or ... advances in laser dentistry. Using the BIOLASE WaterLase® iPlus™ laser, she targets bacteria ...
(Date:6/20/2017)... ... June 20, 2017 , ... Many RNA ... regulatory principles, the research team developed expressRNA, a web platform encompassing computational tools ... reveals at nucleotide resolution the ‘RNA maps’, which demonstrate that RBPs bind to ...
(Date:6/20/2017)... ... , ... John D'Eri, CEO of Rising Tide Car Wash , will ... during the Autism Society of America 's 49th annual conference to be held ... (DJFF) was founded in 2002 as the nation's first autism organization focused exclusively ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... N.J. , June 16, 2017 Datascope Corp. is ... by Datascope Corp. for a potential electrical test failure code.     ... PART NUMBER ... CS100 IABP CS300 IABP ... ...
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/12/2017)... Inc., a biotechnology company focused on the development of novel ... and Head of Virology Kristin Bedard has been invited to ... Beyond meeting sponsored by Life Science Washington.  This Symposium ... PDT at the Agora Conference Center in Seattle, ... joined by other leaders in infectious disease research and the ...
Breaking Medicine Technology: